- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Humoral and cellular response in convalescent COVID-19 lupus patients ; volume:12 ; number:1 ; day:12 ; month:8 ; year:2022 ; pages:1-17 ; date:12.2022
Scientific reports ; 12, Heft 1 (12.8.2022), 1-17, 12.2022
- Urheber
-
Solé, Cristina
Domingo, Sandra
Vidal, Xavier
Cortés-Hernández, Josefina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-17334-5
- URN
-
urn:nbn:de:101:1-2022112709495103886474
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Solé, Cristina
- Domingo, Sandra
- Vidal, Xavier
- Cortés-Hernández, Josefina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interferon lambda regulates cellular and humoral immunity in pristane-induced lupus
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report
The Convalescent
The convalescent
Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
Lupus : Molecular and Cellular Pathogenesis
Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity
Correction: Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients
Interferon lambda regulates cellular and humoral immunity in pristane-induced lupus
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report
The Convalescent
The convalescent
Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
Lupus : Molecular and Cellular Pathogenesis
Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity
Correction: Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients
Interferon lambda regulates cellular and humoral immunity in pristane-induced lupus
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report
The Convalescent
The convalescent
Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
Lupus : Molecular and Cellular Pathogenesis
Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?
Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity
Correction: Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months